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In the previous studies we have shown that the brain-spe-
cifi c transcription factor NZF2b/7ZFMyt1 (Neural Zinc Finger 
Transcription Factor-2b/7-Zinc Finger Myelin Transcription 
Factor-1) is induced signifi cantly in the brain reward pathway after 
chronic cocaine administration and may play a key role in regulat-
ing the locomotor effects of cocaine (Chandrasekar and Dreyer, 
2010). Expressed predominantly in the developing CNS, neural 
precursors and some subpopulations of mature neurons (Kim and 
Hudson, 1992; Bellefroid et al., 1996; Kim et al., 1997; Matsushita 
et al., 2002) NZF-2b/7ZFMyt1 is also expressed in developing 
oligodendrocytes and tightly regulates expression of several mye-
lin-specifi c gene products, such as PLP1, MAL2, etc. (Armstrong 
et al., 1995; Nielsen et al., 2004). NZF2b/7ZFMyt1 interacts with 
the co- repressor Sin3B and actively recruits HDAC1 and HDAC2 
to specifi c genes (Romm et al., 2005).
To further understand the role of NZF2b/7ZFMyt1, we inves-
tigated its effects on modulating cocaine self-infusion in rats. For 
this purpose, we manipulated NZF2b/7ZFMyt1 expression levels 
in the nucleus accumbens (NAc) using lentivirus-mediated overex-
pression or silencing. First we studied the effects of this manipula-
tion on cocaine self-administration. Second, we observed that this 
altered behavior is mediated by histone deacetylase (HDAC) that is 
recruited by NZF2b/7ZFMyt1 for suppression of gene expression 
(Romm et al., 2005). Third we found differential expression changes 
in several downstream target genes after NZF2b/7ZFMyt1 regula-
tion, a possible result from epigenetic modifi cation after cocaine 
INTRODUCTION
Drugs of abuse induce long-term synaptic changes in the brain’s 
reward system. Synaptic plasticity directly underlies addictive behav-
iors after drug exposure (Nestler, 2000; Conrad et al., 2008; Lüscher 
and Bellone, 2008), but the mechanisms involved in these proc-
esses, and how drug-induced neural plasticity is mediated by tran-
scriptional regulation, are still poorly known. Changes in synaptic 
transmission and neuronal morphology results from altered gene 
expression and epigenetic mechanisms, and are thus the emerging 
focus for recent investigations on addiction (Nestler, 2000; Tsankova 
et al., 2004, 2007; Kumar et al., 2005; Renthal et al., 2007). These 
studies support the key role of cocaine-induced transcription factors 
and their implication in chromatin remodeling for drug mediated 
altered gene expression (Berke and Hyman, 2000; Nestler, 2001). 
Transcription factors regulate target genes by recruiting histone 
modifying enzymes, eg., histone acetyl transferases [HATs] and 
histone deactylases [HDACs] (Brami-Cherrier et al., 2005; Kumar 
et al., 2005; Levine et al., 2005). In adult neurons this may be asso-
ciated with learning and memory and in response to psychotropic 
drugs (Guan et al., 2002; Alarcón et al., 2004; Korzus et al., 2004; 
Levenson et al., 2004; Li et al., 2004; Renthal et al., 2007).
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were utilized. A single channel fl uid swivel (Instech Laboratories; 
Plymouth Meeting, CA, USA) was mounted on a balanced arm 
above each chamber. These chambers were equipped with syringe 
pump systems, which consisted of an infusion pump (Razel model 
A-99; Stamford, CT, USA) with a 10-mL plastic syringe connected 
by a single-channel 22-gauge swivel (Instech Laboratories) with 
Tefl on tubing. The tubing could be connected to the animal’s cath-
eter system in order to deliver cocaine solution. Two nose poke 
holes with a 3-cm diameter each and located 4 cm above the fl oor 
were situated on the same wall of each chamber. One of these was 
selected as the active hole for delivering the reinforcer and the other 
as the inactive hole. Nose pokes into both holes were recorded. 
When the number of programmed nose pokes into the active hole 
had been reached, a 40 µl volume of cocaine solution was deliv-
ered per active-nose poking over a period of 2 s, followed by a 
40-s time out. Inactive-nose pokes were recorded as a measure of 
general activity. Three ‘cue’ lights above the active hole were paired 
contingently with delivery of cocaine. Active-nose pokes that were 
performed during the infusion time or during the time out period 
were tabulated but did not result in any further cocaine delivery. 
During infusion of cocaine, the house lights were turned off, and 
the cue lights over the active nose poke were illuminated. During the 
time out period house lights were turned on and the cue lights were 
switch off. Close to the nose poke was a recessed food receptacle into 
which food pellets (45 mg each; Bio-Serv, Frenchtown, NJ, USA) 
could be dispensed from a pellet dispenser. A house light was also 
located within the chamber. Graphic State Notation (Coulbourn 
Instruments, Allentown, CA, USA) was used to program experi-
mental parameters (e.g. schedules of reinforcements, time periods, 
etc.), and tabulate and store session data.
Drug self-administration paradigm. Three groups of animals 
(n = 7) were prepared and were stereotaxically injected with either 
LV-7ZFMyt1, a mix of three LV-7ZFMyt1-shRNAs silencers or 
LV-GFP (control) as described above. After 1 week of recovery, 
rats were returned to the operant chambers and were allowed to 
self-administer cocaine on a FR1 schedule of reinforcement in a 
daily 1-h session. Testing started 2 h after lights off. The animals, 
self-administered cocaine (0.7 mg/kg) per injection. The criteria 
for acquisition of cocaine self-administration were defi ned by a 
constant number of self-infusions over a period of at least three 
consecutive sessions (±20%) (Boyer and Dreyer, 2007). After estab-
lishment of cocaine induced stable behavior (self-infusion) under 
the FR1 schedule of reinforcement, the fi xed ratio requirements were 
raised to FR2, FR3 and then fi nally to FR5, which was maintained 
for the remaining of the experiment. During this whole procedure 
animals were fed with doxycycline (0.02% in 5% sucrose solution) 
to block ectopic gene expression during the operant conditioning 
training period. Once the operant conditioning session is stabilized 
in FR5 for fi ve consecutive days, the animals were fed without doxy-
cycline for 7 days and recording was performed 48 h after regimen 
switch (Session A); thereafter animals were again fed doxycycline for 
7 days and recording was performed 48 h after the switch (Session B) 
and then fed again without doxycycline for another 7 days,  starting 
the recordings 48 h after regimen switch (Session C). At the end of 
this period animals remained fed without doxycycline for 6 days 
and pharmacologically treated over three consecutive days with 
administration. Together these results point to the potential role 
of NZF2b/7ZFMyt1 in regulation of gene expression in cocaine-
induced neural plasticity.
MATERIALS AND METHODS
ANIMAL HANDLING AND SURGICAL PROCEDURES
All animal experiments were carried out in accordance with 
guidelines and regulations for Animal Experimentation, BAG, 
Bern, Switzerland. Male Wistar rats weighing 250–300 g (BRL, 
Fillingsdorf), Switzerland) were used for all the experiments. The 
animals were housed in groups (four per cage) in clear plastic cages 
with wire grid lids. The animals were kept on a 12-h light/dark cycle 
(lights off at 07.00 h), with access to food and water ad libitum. 
For doxycycline treatment, animals were maintained with 0.02% 
doxycycline (Sigma, Steinheim, Germany) and 5% sucrose supple-
mented in water. During the gene over expression period, animals 
were maintained only with 5% sucrose.
INTRAVENOUS CATHETER IMPLANTATION SURGERY
Male Wistar rats (250–280 g) were individually housed under a 
constant 12 h light:dark cycle (lights off at 07.00 h) with free access 
to food and water. Rats were anaesthetized with a cocktail mixture 
of ketamine (10 mg/kg) and xylazine HCl (0.1 mg/kg) adminis-
tered i.p. with a volume of 1 mL/kg. The surgical procedures were 
performed according to previous publications (Boyer and Dreyer, 
2007) and consisted of making an opening between the breastbone 
and the clavicle to expose the jugular vein and a SILASTIC catheter 
(15-µL dead volume) was inserted into the external jugular vein 
by a discrete incision. The heparinized catheter was inserted 3 cm 
into the jugular vein and secured with sutures. The catheter was 
then passed under the skin and fi xed in the mid-scapular region. 
The catheter, which consisted of a SILASTIC tubing 14 cm long 
(Instech Laboratories, Paolo Alto, USA), was fi tted to a 22 gauge 
guide cannula (Instech Laboratories) that was custom bent and 
embedded in dental cement on a circular 3-cm mercylene mesh 
base. For the fi rst 3 days after surgery, the catheters were fl ushed 
daily with 0.1 mL of saline mixed with heparin (100 U/mL) and 
gentamicin (1 mg/kg, Sigma, Steinheim, Germany). Thereafter, 
the catheters were fl ushed with a saline–heparin mixture after 
each session to prevent clotting.
Stereotaxic surgery
Stereotaxic surgery and lentiviral injection were performed accord-
ing to previous publications (Bahi et al., 2004; Boyer and Dreyer, 
2007). Rats were anesthetized with ketamine-xylazine (10 mg/kg 
and 0.1 mg/kg, Streuli and Co. AG) administered i.p. Animals were 
bilaterally injected into the NAc with 2 µL of concentrated len-
tiviral expression system stock (0.2 mg/mL of p24, correspond-
ing to 8 × 109 IU/mL). The injections were performed bilaterally 
at the following coordinates, as calculated from bregma and the 
dura mera: anterior +1.4; lateral ±1.2; ventral −6.8 (Paxinos and 
Watson, 1998).
Cocaine operant self-administration
Apparatus. Standard operant chambers (Coulbourn Instruments, 
Allentown, CA, USA) housed in ventilated sound-attenuating cubi-
cles (Coulbourn Instruments) with fans to mask outside noise 
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pMDG-VSV-G were co-transfected into human embryonic kidney 
(HEK) 293T cells to produce the viral particles (Bahi et al., 2004; 
Boyer and Dreyer, 2007). The viral titers were determined by p24 
antigen measurements (KPL, USA). For the in vivo experiments, 
the different viral stocks were matched for viral particle content 
and used at 0.2 mg/mL of p24.
MOLECULAR ANALYSIS
RNA isolation and real-time quantitative PCR (qRT-PCR)
Post behavioral experiments, animals were sacrifi ced and the 
NAc regions were dissected out from 1-mm thin slice sections 
using rat brain matrix (RBM-3000, ASI instruments, inc, USA), 
for both RNA and protein extraction. Rat brain NAc region 
(micro-dissected from lentivirus treated animals) or HEK-293 
cells infected with lentiviruses for gene expression were homog-
enized in TRIzol reagent (Invitrogen, Basel, Switzerland), accord-
ing to manufacturers protocol. After being washed with 70% and 
100% (v/v) ethanol, RNA pellets were dissolved in DEPC-treated 
H
2
O. Quality and integrity of the RNA was analyzed and quan-
tifi ed accurately by a bioanalyzer, and 2%agarose gel. All RNA 
samples were stored at −70°C. The cDNAs were prepared using 
4 µg of RNA from each sample reverse transcribed at 42°C for 
30 min with 1 µg of Oligo(dT) or random hexamers, 5X fi rst 
strand buffer, 100-mM DTT, 10-mM dNTP, Rnasin (Invitrogen, 
Basel, Switzerland) and M-MLV reverse transcriptase (Promega, 
Wallisellen, Switzerland). Primer sets were designed to amplify 
100–200 bp products, using PRIMER3 software2. PCR reaction 
mixtures included cDNAs in optimum dilution, the SYBR-Green 
qPCR Master mix (BioRad Reinach, Switzerland), 10-µM prim-
ers, in a total reaction volume of 20 µl. Expression profi ling was 
done with dissociation curves using iCycler (BioRad). Cycling 
parameters were 95°C for 4 min followed by 40 cycles of 20°C/s 
temperature transition rate up to 95°C (30 s), 62°C (45 s), fol-
lowed by melting curve analysis. All reactions were performed 
in triplicates with reference dye normalization (β-actin or 
Cyclophilin) and the median Ct (Cycle threshold) value was used 
for analysis. To determine the linearity and detection limit of the 
assay, cDNA samples were amplifi ed for successive 10-fold dilu-
tions in a series of real-time PCRs, using a duplicate assay on each 
dilution, so that the correlation coeffi cient could be calculated 
from the standard curve of Ct values. The ΔCt for each candidate 
was calculated as: ΔCt = [Ct (candidate) − Ct (Cyclophilin or 
β-actin)]. The relative abundance of each target can be calculated 
as the ratio between treated and untreated samples (Bahi et al., 
2004; Mühlbauer et al., 2004; Boyer and Dreyer, 2007). The PCR 
reaction was evaluated by melting curve analysis and by check-
ing the PCR products on 2% agarose gel. Comparisons were 
made between cocaine and saline groups, and signifi cance was 
calculated using two-way anova followed by Bonferroni post hoc 
tests and the level of statistical signifi cance was set at P < 0.001. 
Data were expressed as means ± SEM.
The following primers sets were used for amplifi cation: NZF-
2b/7ZFMyt1: forward 5′-GCA GAC CTC AGT TGT CCT ACC-3′ 
and reverse 5′-CTT GGA TAC CAG GTG CTC AG-3′; Cyclophilin: 
forward 5′-GTG AGA AGG GCT TTG GCT AC-3′ and reverse 
a single daily injection of sodium butyrate (NaB) (100 mg/kg, 
i.p.) a histone deacetylase (HDAC) inhibitor (Sigma, Steinheim, 
Germany), and self-administration was recorded 30 min after the 
i.p. injection. After this schedule, one-third of each group of the 
animals were killed by decapitation 24 h after the last cocaine self-
administration session (under sodium butyrate treatment); half of 
the remaining animals from each groups were fed doxycycline and 
the other half without doxycycline for 5 days (to remove the NaB 
from the system) before being sacrifi ced. NAc from brain tissues 
were dissected and used either for Western blot or quantitative 
real-time PCR analysis. Sections from frozen brains were used for 
immunohistochemistry.
PREPARATION OF LENTIVIRUSES
LV-7ZFMyt1 lentiviral expression constructs
The lentiviral expression construct of the Myelin transcription 
factor 1 (MYT1) gene was generated from the MYT1 plasmids 
kindly provided by Prof. Armstrong′s lab (Uniformed Services 
University of the Health Sciences, Bethesda). The 7 zinc fi nger 
MYT1 gene coding region along with the Myc tag (∼3.9 kb) from 
pMycMyt1-7zf-IRES/RED expression vector was fi rst digested with 
EcoR I and sub-cloned into pDRIVE vector (QIAGEN). MYT1 
gene ORF was then digested with SnaB I and Xho I from pDRIVE 
and cloned using Hpa I and Xho I sites into the lentiviral vector 
pTK-431 that expresses the gene of interest under control of a Tet-
Off promotor. The clones were verifi ed by conventional methods. 
The green fl uorescent protein (GFP) expressing lentiviral vector 
pTK433 (Bahi et al., 2004; Boyer and Dreyer, 2007) was used as 
a control vector.
LV-7ZFMyt1-siRNA lentiviral expression constructs
Three different siRNAs, targeting different regions of the MYT1 
mRNA sequence, were designed to silence NZF-2b/7ZFMyt1 
expression in vitro and in vivo. The following targets within the 
MYT1 mRNA sequence were selected, based on Hannon’s design 
criterion1: fi rst target: bp 1127–1145; second target: bp 2239–2268 
and third target: bp 3487–3507. To each oligo, a Xho-I restriction 
site was added at 3’, and a U6-3’-specifi c 10mer at 5’. Using the 
pSilencer 1.0-U6 (Ambion, UK) as a template and a U6 promoter-
specifi c forward primer containing BamH-I restriction site (5’-
GCG GAT CCC GCT CTA GAA CTA GTG C-3’), each siRNA target 
was added to the mouse U6 promoter by PCR, using the following 
PCR program: 120 s at 93°C (initial denaturation) followed by 35 
cycles (45 s at 92°C, 45 s at 64°C and 45 s at 72°C) in 5% dimethyl 
sulphoxide (Sigma, Lucern, Switzerland). The PCR product was 
directly ligated into pDRIVE vector from QIAGEN PCR Cloning 
Kit (QIAGEN, Basel, Switzerland). The shRNA insert along with 
the U6 promoter was then digested with BamH-I and Xho-I, and 
sub-cloned into similar sites in the lentiviral vector pTK-431, and 
sequenced to verify the integrity of each construct.
Lentivirus production
The lentiviral vector expression plasmids (either pTK431-7ZFMyt1, 
pTK433-GFP or pTK431-U6-7ZFMyt1-siRNAs), along with the 
packaging construct plasmid pΔNRF and the envelope plasmid 
1http://katahdin.cshl.org:9331/RNAi/html/rnai.html 2http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi
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5′-TTC TCG TCA GGA AAG CGG-3′; β-actin: forward 5′-AGC 
CAT GTA CGT AGC CAT CC-3′ and reverse 5′-CTC TCA GCT 
GTG GTG GTG AA-3′; BDNF: forward 5′-GGT TCG AGA GGT 
CTG ACG AC-3′ and reverse 5′- CAA AGG CAC TTG ACT GCT 
GA-3′; TrkB forward 5′- CCT CGT CGG AGA AGA TCA AG -3′ 
and reverse 5′- CGT GGT ACT CCG TGT GAT GT-3′; REST1: 
forward 5′- CGA GTT GAT GCC TGT TGG AGA C-3′ and reverse 
5′- TGC TTC AAA TAC GGG CTG GG-3′; NAC1: forward 5′- GCT 
CTT CCT GAG CAG GTC GT-3′ and reverse 5′- GTG CCT GTC 
ACA AGC TCC AG-3′. Urokinase: forward 5′- CAG ATC CGA 
TGC TCT TAG CC -3′ and reverse 5′- TAG AGC CTT CTG GCC 
ACA CT-3′; Dopamine transporter: forward 5′- GTT CTA CGG 
CGT CCA GCA -3′ and reverse 5′- TGA CCA CGA CCA CAT ACA 
GG-3′; CD81: forward 5′- TGA TCC TGT TTG CCT GTG AG -3′ 
and reverse 5′- CAG TTG AGC GTC TCA TGG AA-3′; Dopamine 
D2 receptor: forward 5′- CAT TGT CTG GGT CCT GTT CCT -3′ 
and reverse 5′- GAC CAG CAG AGT GAC GAT GA-3′; Dopamine 
D3 receptor: forward 5′- GGG GTG ACT GTC CTG GTC TA -3′ 
and reverse 5′- TGG CCC TTA TTG AAA ACT GC-3′.
Immunohistochemistry
To check the expression of NZF-2b/7ZFMyt1 after lentiviral injec-
tions, rats were decapitated, brains were quickly removed, immediately 
frozen in isopentane (at −30°C for 3 min) and kept at −25°C. Coronal 
sections were cut at 14 µm in a cryostat and placed on gelatinized 
glass slides, air−dried at room temperature for 20 min and kept at 
−25°C until further processing. Brain sections were fi xed for 10 min 
in cold acetone and washed three times in 1 × phosphate-buffered 
saline (PBS). Non-specifi c binding sites were blocked by incubating 
slices for 1 h in 1 × PBS containing 1% bovine serum albumin, 1% 
Triton X-100 and 3% normal goat serum. Sections were then incu-
bated overnight at 4°C with primary antibodies specifi cally against 
either endogenous NZF-2b/7ZFMyt1 (rabbit polyclonal anti-MYT1 
antibody; 1:15, Sigma prestige antibodies-HPA006303) or against Myc 
for ectopic Myc-tagged protein (rabbit polyclonal anti-Myc-tag anti-
body; 1:1000, Abcam-ab9106), for neuronal marker, NeuN (mouse 
monoclonal anti-neuronal-nuclei; 1:1000, Chemicon-MAB 377), 
for HDAC2 (mouse monoclonal to Histone deacetylase-2; 1:1000, 
Abcam-ab12169), for dopaminergic neuronal marker, TH (rabbit 
polyclonal to Tyrosine hydroxylase protein; 1:750; Abcam, ab112-
100), for oligodendrocyte marker, Oligo2 (rabbit polyclonal; 1:500, 
Abcam, ab33427), for Lingo1 (rabbit polyclonal to LINGO-1; 1:500, 
Abcam-ab23631). Antibodies were diluted in 1 × PBS containing 
0.1% Triton X-100 and 1% normal goat serum. Thereafter, slices were 
washed three times in 1 × PBS, and incubated for 2 h in the secondary 
antibody (Texas red-conjugated goat anti-rabbit immunoglobulin G, 
1:5000) or (FITC-conjugated goat anti-mouse IgG, 1:5000, Invitrogen 
65-6411) in 1 × PBS containing 0.1% Triton X-100. The sections 
were cover-slipped with a medium containing glycerol in PBS (AF1 
mounting solution, Citifl uor Ltd., London). For double and triple 
staining experiments the nuclei were stained by 30-min incubation 
with Hoechst 33342 (1:1500, Sigma, Steinheim, Germany). Negative 
controls included omission or substitution of primary antibodies.
Fluorescence microscopy was performed to observe the stained 
sections using a multi-fl uorescence microscope (Axioplan 2 imag-
ing; Zeiss). Fluorophores (FITC and Texas red) used were detected 
with the appropriate detecting systems (HAL 100). FITC was 
excited at 495 nm and was detected through a light path rang-
ing 510–550 nm. Texas red was exited at 570 nm and was detected 
through a light path ranging 600–660 nm. Stained sections were 
visualized, photographed using a multichannel camera (Axiocam, 
Zeiss) combined with acquisition software (Axiovision system 3.1) 
and recorded on CD (Boyer and Dreyer, 2007).
Protein isolation and western blotting
Microdissected NAc regions from lentiviral injected rats 
(150–200 mg) or transfected HEK293T cells were homogenized in 
buffer (Tris-HCl 50 mm, pH 7.5; NaCl 120 mm; CaCl2 1.5 mm; 
MgCl2 5 mm; KCl 5 mm; EDTA 5 mm) with a protease inhibi-
tor mixture (Sigma, St Louis, MO, USA; 1 mL/20 g of tissue). The 
homogenates were then solubilized with 1% digitonin, followed by 
the addition of secondary solubilization buffer [Tris-HCl 50 mm, 
pH 7.6; NaCl 150 mm; 1% Nonidet-P40; 0.5% sodium deoxycholate; 
EDTA 2 mm; sodium ortho-vanadate 1 mm; phenylmethylsulphonyl 
fl uoride (PMSF) 1 mm; 1% Triton X-100]. Protein concentration 
was determined by the DC protein assay method (Bio-Rad) using 
BSA as a standard. The protein extracts (20 µg) were subjected to 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred 
into Immobilon PVDF membranes (Millipore). Blots were blocked 
with 5% non-fat dried milk dissolved in TBST (Tris 10 mm; NaCl 
150 mm; 0.1% Tween-20) for 1 h at room temperature. The blots 
were then incubated with primary antibodies for either Myc tag (rab-
bit polyclonal; 1:1000; Abcam, ab9106) or MYT1 (rabbit polyclonal; 
1:15; Sigma prestige antibodies HPA006303) overnight at 4°C. Blots 
were washed three times with TBST and incubated for 1 h with the 
peroxidase-conjugated secondary antibody solution. Proteins were 
then visualized using enhanced chemiluminescence (Millipore, Basel, 
Switzerland). For house keeping gene, loading control measurements, 
membranes were washed for 30 min in TBST and placed in stripping 
solution (glycine-HCl 25 mm, pH 2.0, 1% SDS) for 30 min and were 
blocked and put for antibody binding as described above for β-actin 
detection (1:4000; Sigma) using the same membrane.
STATISTICAL ANALYSIS
For statistical analysis two-way repeated-measures analysis of variance 
Anova was used to compare both lentiviral groups and drug treatment 
in the presence or absence of doxycycline, using GraphPad PRISM 
(V3.0, GraphPad, San Diego, CA, USA). For self-administration two-
way Anova with time as the within-subject factors and lentiviral gene 
expression as the between-subject factors followed by Bonferroni 
post hoc comparison was used. Effects of the HDAC inhibitor during 
the totality of the FR sessions were analyzed by using treatment and ses-
sion as factors of variation, between groups of rats. qPCR results were 
analyzed by two-way Anova, with drug treatment (presence or absence 
of doxycycline) as the within-subject factors and lentiviral-mediated 
gene expression as the between-subject factors followed by Bonferroni 
post hoc comparison. Statistical signifi cance was set at P ≤ 0.05.
RESULTS
LENTIVIRAL-MEDIATED NZF-2b/7ZFMyt1 EXPRESSION IN THE NAc 
INHIBITS COCAINE SELF-ADMINISTRATION
The effects of NZF-2b/7ZFMyt1 overexpression or silencing in the 
NAc on cocaine self-administration were tested under FR5 schedule. 
Three groups of animals (n = 7) were used for the study. Stereotaxical 
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injections were performed into the NAc shell; one group was injected 
LV-7ZFMyt1 (a doxycycline-regulatable lentiviral vector), the second 
group LV-7ZFMyt-shRNAs (a mixture of three non-regulatable lentivi-
ral vectors expressing shRNAs targeted against NZF-2b/7ZFMyt1) and 
the third group the regulatable LV-GFP (control group). LV-7ZFMyt1 
expression and specifi c silencing effi ciency with LV-7ZFMyt1-siRNAs 
have been confi rmed in vitro (Chandrasekar and Dreyer, 2010). After 
intravenous catheterization, training and acquisition of cocaine SA 
under FR5, the effects of LV-mediated gene expression were assessed 
over a period of 4–5 weeks. During the training period all animals 
were fed doxycycline to block ectopic gene expression in the NAc (see 
Materials and Methods). Once animals have been stabilized under FR5 
for fi ve consecutive days, they were fed without doxycycline for another 
5 days (Session A). Under these conditions the control LV-GFP group 
exhibited strong self-administration with a mean of 13.7 infusions per 
session. The LV-7ZFMyt1 group, overexpressing NZF-2b/7ZFMyt1 
in the NAc, displayed a signifi cant 2.4-fold decrease in cocaine self-
administration compared to the control LV-GFP group, with a mean 
of 5.7 infusions per session (Figure 1, F
2,36
 = 37.70, P < 0.0001). By 
contrast, in the third group, silencing of NZF-2b/7ZFMyt1 in the 
NAc yielded a 1.5 fold increase (P > 0.05) in self-administration over 
the LV-GFP group and a very signifi cant 3.6-fold increase over the 
LV-7ZFMyt1 group (P < 0.001).
Thereafter all animals were fed doxycycline for 7 days and self-
administration was recorded 48 h after switching regimen, once 
full switch-off in gene expression has been established (Session B). 
Under these conditions, the LV-GFP group showed no signifi cant 
change in cocaine SA with a mean of 11.7 infusions per session, in 
agreement with previous studies showing that GFP overexpression 
in the NAc does not affect behavior (Bahi et al., 2004, 2005; Bahi and 
Dreyer, 2005; Boyer and Dreyer, 2007). Under this regimen, ectopic 
expression of NZF-2b/7ZFMyt1 is repressed in the LV-7ZFMyt1 
group, which showed a signifi cant 1.7 fold increase in self-admin-
istration compared to the same group in Session A, with a mean of 
9.8 infusions per session (Figure 1, F
2,36
 = 1.18, P = 0.3189) and no 
signifi cant change compared to control LV-GFP group (P > 0.05). 
As expected self-administration of the LV-7ZFMyt1-siRNA group 
was not affected by regimen switch, with a mean at 21.4 self-infu-
sions per session, resulting in a 1.8-fold (P < 0.05) and 2.2-fold 
(P < 0.01) increase compared to the LV-GFP and the LV-7ZFMyt1 
group respectively.
Finally doxycycline was again removed and cocaine self-
 administration was recorded 48 h after regimen change for fi ve 
consecutive days (Session C). Under these conditions, which reca-
pitulate gene expression of Session A, self-administration in the 
LV-GFP group (control) was unchanged, with a mean of 15.4 infu-
FIGURE 1 | Differential expression of NZF-2b/7ZFMyt1 in the Nucleus 
Accumbens (NAc) alters cocaine self-administration. Animals injected with 
regulatable LV-7ZFMyt1, LV-GFP and non-regulatable LV-7ZFMyt1-siRNAs were 
used. After surgery, recovery and training, rats (n = 7) were subjected to 
cocaine self-administration (1 h/day) under FR5 schedule over the three 
consecutive sessions. Session A: animals were fed without doxycycline for 
6 days; Session B: then animals were fed doxycycline in the drinking water for 
6 days; Session C: fi nally animals were switched back and fed again without 
doxycycline (see Materials and Methods). Session A: Ectopic expression of 
NZF-2b/7ZFMyt1 in the NAc inhibits cocaine self-administration, whereas local 
knockdown of the NZF-2b/7ZFMyt1 promotes self-infusion. Session B: 
doxycycline-mediated inhibition of ectopic NZF-2b/7ZFMyt1 expression (black 
bar) leads to reversal of the cocaine self-administration suppression (compare 
sessions A with B, black bars), and self-infusion is comparable to the control 
LV-GFP level. Session C: removal of doxycycline reverses to the initial behaviors 
observed in session A. Data shows the means ± SEM of self-infusions of 
cocaine in the three sessions. *P < 0.05, **P < 0.01 and ***P < 0.001, 
represent values signifi cantly different from Lenti-7ZFMyt1 group;+P < 0.05,
++P < 0.01 and +++P < 0.001 represent values signifi cantly different from 
Lenti-GFP group, two-way ANOVA, Bonferroni post hoc tests.
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sions per session, whereas ectopic expression of NZF-2b/7ZFMyt1 
in the NAc in the LV-7ZFMyt group induced a signifi cant 2.6-fold 
drop compared to the LV-GFP group, with a mean of 6 infusions 
per session (F
2,36
 = 37.70, P < 0.0001). In the LV-7ZFMyt1-siRNA 
group, a mean at 26.6 self-infusions per session were recorded, i.e. 
a 1.7 (P < 0.01) and 4.4-fold (P < 0.001) increase over the LV-GFP 
and the LV-7ZFMyt1 group, respectively.
HDAC INHIBITION BY SODIUM BUTYRATE BLOCKS NZF-2b/
7ZFMyt1-MEDIATED SUPPRESSION OF COCAINE SELF-ADMINISTRATION
NZF-2b/7ZFMyt1 regulates neural transcription partly via its 
interaction with co-repressors Sin3B and recruitment of histone 
deacetylases (HDACs) for suppression of gene expression (Romm 
et al., 2005). HDAC inhibition affects behavior by augmenting 
cocaine-mediated histone modifi cations (Kumar et al., 2005; 
Renthal et al., 2007). To test whether the decrease in cocaine self-
administration observed in the LV-7ZFMyt1 group is mediated by 
NZF-2b/7ZFMyt1-HDAC interaction, we used sodium butyrate 
(NaB), a widely used non-specifi c inhibitor of HDACs which pro-
motes cocaine-induced behavior (Kumar et al., 2005; Sun et al., 
2008). At the end of Session C animals received a daily dose of 
100 mg/kg of NaB for three consecutive days, 30 mins before the 
cocaine self-administration session (see Materials and Methods). 
NaB treatment induced a signifi cant 2.4-fold increase (P < 0.01) in 
the LV-7ZFMyt1 group compared to the same group in the Session 
C (i.e. without doxycycline and NaB) with a mean of 14.5 self-
 infusions of cocaine per session (Figure 2, F
2,24
 = 31.27, P < 0.0001). 
NaB treatment in the LV-7ZFMyt1 group brought back cocaine 
self-administration to the level observed in the control LV-GFP 
group. The two other groups (LV-GFP or LV-7ZFMyt1-siRNA 
groups) displayed no signifi cant behavioral changes upon NaB 
treatment (F
1,24
 = 0.96, P = 0.3359) with a mean of 16.3 and 21.4 
self- infusions, respectively.
QUANTIFICATION OF NZF-2b/7ZFMyt1 LEVELS AFTER IN VIVO LV-7ZFMyt1 
EXPRESSION IN THE NAc
RNA from the NAc was isolated at the end of the behavioral experiments 
(see Materials and Methods) and NZF-2b/7ZFMyt1 mRNA levels were 
measured by qRT-PCR. As shown in Figure 3, animals injected with 
LV-7ZFMyt1 displayed a ∼5-fold increase in expression of NZF-2b/
7ZFMyt1 in the NAc, compared to LV-GFP control (endogenous 
expression) in the absence of doxycycline (Figure 3A, F
2,12
 = 96.05, 
P < 0.0001). When fed doxycycline (shutting off expression of ectopic 
LV-NZF-2b/7ZFMyt1 in the NAc) the expression decreased to a mere 
∼1.9-fold compared to LV-GFP control (F
1,12
 = 22.85, P = 0.0004). 
Control genes, e.g. cyclophilin or β-actin mRNA levels, remained 
unchanged. Animals injected with LV-7ZFMyt1-siRNAs in the NAc 
displayed a ∼4.3-fold decrease in NZF-2b/7ZFMyt1 mRNA in the NAc, 
compared to controls under all regimens (F
2,12
 = 29.78, P < 0.0001). 
Doxycycline blocks ectopic NZF-2b/7ZFMYT1 expression but not 
endogenously expressed NZF-2b/7ZFMYT1, while the LV-7ZFMyt1 
silencers block both ectopic and endogenous NZF-2b/7ZFMYT1 
expression. Cocaine self-administration induced a 5.6-fold increase 
in NZF-2b/7ZFMYT1 expression in the control animals (LV-GFP) 
over naive animals (saline controls), correlating with our earlier obser-
vation (Chandrasekar and Dreyer, 2010). Western blot analysis of 
protein expression confi rmed the expression changes observed at the 
mRNA levels (Figure 3B). Together these data show that behavioral 
changes observed in cocaine self-administration is clearly related to 
expression changes of NZF-2b/7ZFMyt1.
NZF-2b/7ZFMyt1 RECRUITS HDAC2 AND COLOCALIZES IN THE NUCLEI OF 
THE NEURONS AFTER LENTIVIRAL-MEDIATED OVEREXPRESSION IN THE 
NAc
Our previous studies showed that endogenous NZF-2b/7ZFMyt1 
protein level does not change between sessions in the control 
LV-GFP group and that overexpression in the LV-7ZFMyt1 group 
FIGURE 2 | The HDAC inhibitor Sodium Butyrate (NaB) reverses inhibition 
of self-administration mediated by NZF-2b/7ZFMyt1. At the end of Session 
C (Figure 1), animals fed without doxycycline were administered NaB (100 mg/
kg, i.p.) 30 min prior to each cocaine self-administration tests, for three 
consecutive days. Values represent means ± SEM of self-infusions of cocaine in 
the three LV-treated groups (n = 7). NaB treatment reverted the inhibition of 
cocaine self-administration observed upon 7ZFMyt1 overexpression in the NAc 
to levels comparable to the control LV-GFP group. Neither LV-GFP nor LV-
7ZFMyt1-siRNA group showed any statistically signifi cant change after NaB 
treatments. *P < 0.05, **P < 0.01 and ***P < 0.001, represents values 
signifi cantly different for the same groups compared between session C (no 
NaB) and session D (with NaB), two-way ANOVA, Bonferroni post hoc tests.
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results in nuclear localization of NZF-2b/7ZFMyt1, predominantly 
in neurons (Chandrasekar and Dreyer, 2010). These observa-
tions were further analyzed after self-administration (Figure 4). 
LV-7ZFMyt1 group without doxycycline displayed strong expres-
sion of NZF-2b/7ZFMyt1 when stained with anti-Myt1 antibody 
(Figures 4A–E). Double-staining with Hoechst (staining all cell 
nuclei) showed co-localization of NZF-2b/7ZFMyt1 protein with 
some, but not all nuclei, suggesting a cell-type specifi c localization 
(Figure 4A). Double immuno-staining with the neuronal nuclei-
specifi c marker NeuN shows that NZF-2b/7ZFMyt1 is predomi-
nantly expressed in the neuronal nuclei and co-localizes with NeuN 
(Figure 4B), with spatial segregation into discrete nuclear domains 
similar to the sites of active transcription. Double-staining with anti-
TH (Tyrosine Hydroxylase, a dopaminergic neuron specifi c marker) 
showed that NZF-2b/7ZFMyt1 expression is strongly co-localized 
with nuclei of the TH-immunoreactive projection areas in the NAc 
(Figure 4C). Furthermore, triple-staining with anti-Oligo2 (an oli-
godendrocytic nuclei marker) along with Hoechst (staining all cell 
nuclei), showed co-localization of NZF-2b/7ZFMyt1 protein with 
a few Oligo2 positive nuclei, indicating a limited expression in oli-
godendrocyte lineage cells (Figure 4D) In addition, previous studies 
have shown that NZF-2b/7ZFMyt1 is not colocalized in GFAP-posi-
tive glial cells (Chandrasekar and Dreyer, 2010). It should be noted 
that the lentiviral-mediated, ectopic expression of NZF-2b/7ZFMyt1 
in the NAc is clearly very restricted along the needle tract, as observed 
using anti-Myc antibody, and treatment with doxycycline induced 
a potent inhibition (>85%) of ectopic expression in the target area 
(Figure 4E); this shows the tight regulation of NZF-2b/7ZFMyt1 pro-
tein levels mediated by doxycycline-switch in LV-7ZFMyt1 group.
Previous studies have shown that NZF-2b/7ZFMyt1 interacts 
with Sin3B and that, for its transcriptional suppressor function, it 
actively recruit histone deacetylases-1 and -2 (HDACs) (Romm et al., 
FIGURE 3 | NZF-2b/7ZFMyt1 expression in the NAc after cocaine self-
administration. (A) NAc samples were retrieved after the end of the behavioral 
studies (cocaine self-administration) from animals fed either with or without 
doxycycline. NZF-2b/7ZFMyt1 mRNA expression levels were determined by 
qRT-PCR relative to Cyclophilin. LV-7ZFMyt1 group displayed increased 
expression of NZF-2b/7ZFMyt1 compared to LV-GFP control, whereas in 
LV-7ZFMyt1-siRNA group a signifi cant decrease in NZF-2b/7ZFMyt1 expression 
compared to LV-GFP was observed. Doxycycline regimen that inhibits ectopic 
expression resulted in a signifi cant decrease in NZF-2b/7ZFMyt1 levels in the 
LV-7ZFMyt1 group. *P < 0.05; **P < 0.01; ***P < 0.001 represents values 
signifi cantly different from LV-GFP group, and +P < 0.05; ++P < 0.01; +++P < 0.001 
represents values signifi cantly different from LV-7ZFMyt1 group, by two way 
ANOVA, Bonferroni post hoc tests. (B) Western blot analysis of NZF-2b/7ZFMyt1 
protein levels in the NAc of the LV-treated animals after cocaine self-
administration (see Materials and Methods). Western blots from gels loaded 
with 20 µg protein/lane were analyzed with antibody against NZF-2b/7ZFMyt1. 
LV-7ZFMyt1 group displays high protein expression compared to GFP control, 
whereas LV-7ZFMyt1-siRNA group shows a strong inhibition in the 
NZF-2b/7ZFMyt1 levels, correlating with the mRNA levels observed. The 
membranes were reprobed with antibodies against β-actin to serve as standard 
protein control. As with mRNA profi le, doxycycline inhibits the ectopic 
NZF-2b/7ZFMyt1 expression level to that of the control GFP group.
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FIGURE 4 | Lentivirus-mediated expression of NZF-2b/7ZFMyt1 recruits 
and co-localizes with HDAC2 in neuronal nuclei in the NAc. Animals were 
sacrifi ced at the end of cocaine self-administration behavioral tests, either in 
the presence or absence of doxycycline. Brains were dissected out and 
processed for immuno-histochemistry (see Materials and Methods). (Scale 
bar: 20 µm). (A) Double immunostaining with anti-Myt1 antibody (red) and 
Hoechst nuclei staining (blue) (100× magnifi cation); merged image shows that 
the NZF-2b/7ZFMyt1 expression is localized in most if not all cell nuclei in the 
NAc. (B) Double immunostaining with anti-Myt1 antibodies for detecting 
NZF-2b/7ZFMyt1 protein (green) and anti-NeuN (a neuronal nuclei marker; red) 
(100× magnifi cation); merged image shows that NZF-2b/7ZFMyt1 
predominantly co-localizes (yellow) with NeuN within the nuclei. (C) Double 
immunostaining with anti-Myt1 (green) and anti-TH (Tyrosine hydroxylase; 
red) antibodies (63× magnifi cation); merged image shows that most of the 
NZF-2b/7ZFMyt1 expression is localized in TH-immunoreactive projection 
areas (yellow) in the NAc. (D) Triple-staining with anti-Myt1 (red), Hoechst 
(nuclei staining; blue) and anti-Oligo2 (oligodendrocytic marker; green) 
antibodies (63× magnifi cation). While Hoechst (blue) stains all nuclei 
non-specifi cally, regardless of the cell type, the oligodendrocytic marker 
Oligo2 shows a distinct profi le compared to Myt1. Merged image shows that 
only few cells (arrows) display colocalization of Oligo2 and NZF-2b/7ZFMyt1 
(yellow) in the NAc. (continued)
2005), which are histone modifying enzymes involved in maintain-
ing suppressive chromatin structure for the target genes. To check 
whether NZF-2b/7ZFMyt1 interacts with HDAC2 for exerting its 
suppressive function, – correlating with the behavioral studies 
with HDAC inhibitors, – triple-staining with anti-HDAC2 anti-
bodies were performed. The results showed that NZF-2b/7ZFMyt1 
is strongly co-localized with HDAC2, and together is localized to 
the neuronal nuclei (Figure 4F).
In addition, Myt1 interacts with Lingo1 which regulates its tran-
scriptional activity based on recruitment to cytoplasm (Llorens et al., 
2008). In our previous studies we proposed a model wherein ectopic 
expression of NZF-2b/7ZFMyt1 results  probably in saturating this 
negative regulation, resulting in the availability of NZF-2b/7ZFMyt1 
for transcriptional regulation of its target genes. In order to check 
whether this holds true in the self-administration paradigm, we per-
formed immuno-staining of the NZF-2b/7ZFMyt1 overexpression 
group NAc region with Myt1 and Lingo1 antibodies. The results show 
that Lingo1 staining is restricted to the cytoplasm, whereas NZF-
2b/7ZFMyt1 expression is predominantly localized to the nucleus, 
as evidenced from the triple staining with Hoechst (nuclei staining) 
(Figure 4G), suggesting that ectopic expression of NZF-2b/7ZFMyt1 
relieves it from the negative regulatory effect caused by Lingo1.
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FIGURE 4 | (continued) Lentivirus-mediated expression of NZF-2b/7ZFMyt1 
recruits and co-localizes with HDAC2 in neuronal nuclei in the NAc. (E) Low-
magnifi cation (20×) of ectopic NZF-2b/7ZFMyt1 labeling with anti-Myc in the 
needle tract of the NAc either in the presence (red) or absence (green) of 
doxycycline, showing a tightly regulatable expression of ectopic, Myc-tagged NZF-
2b/7ZFMyt1. (F) Triple immunostaining with anti-Myt1 (green) and anti-HDAC2 
(red) antibodies (63× magnifi cation); merged image shows co-localization of NZF-
2b/7ZFMyt1 with HDAC2 in the nuclei of the neurons. (G) Triple-staining with anti-
Myt1 (red), Hoechst (nuclei staining; blue) and anti-Lingo1 (component of the 
Nogo-receptor complex; green) antibodies (63× magnifi cation). Lingo1 is restricted 
to the cytoplasm whereas NZF-2b/7ZFMyt1 is localized to the nuclei of the 
neurons as evident from the Hoechst nuclei staining (blue).
NZF-2b/7ZFMyt1-MEDIATED BEHAVIORAL CHANGES CORRELATE WITH 
DOWN-STREAM MOLECULAR ADAPTATIONS IN THE NAc
In our previous studies we have shown that NZF-2b/7ZFMyt1 
expression leads to induction of REST1 and NAC1 and inhibi-
tion of BDNF (Chandrasekar and Dreyer, 2010). Expression of 
some downstream signaling genes with putative binding sites for 
NZF-2b/7ZFMyt1 were further tested upon self-administration 
paradigm (Figure 5).
NZF-2b/7ZFMyt1 expression strongly induces NAC1 in the NAc 
(Figure 5A, F
2,12
 = 30.88, P < 0.0001). LV-7ZFMyt1 group displays a 
∼3-fold increase in NAC1 expression compared to LV-GFP-treated 
controls (Figure 5A, F
2,12
 = 42.64, P < 0.0001). Doxycycline that 
suppresses local ectopic expression of NZF-2b/7ZFMyt1 did not 
affect NAC1 expression profi le in LV-GFP-treated control animals, 
but in LV-7ZFMyt1 treated animals it induced a ∼2.5-fold suppres-
sion of NAC-1 (Figure 5A, F
1,12
 = 23.90, P = 0.0004). No signifi cant 
change in expression was observed in LV-7ZFMyt1-siRNAs group 
compared to LV-GFP group under the same conditions.
NZF-2b/7ZFMyt1 displays 13 putative conserved binding site 
modules in the BDNF promoter and it down-regulates its expres-
sion (Chandrasekar and Dreyer, 2010). Further confi rmation was 
achieved under self-administration paradigm, where LV-7ZFMyt1-
treated animals showed a 1.6 fold inhibition of BDNF mRNA levels 
compared to LV-GFP group (Figure 5B, F
2,12
 = 70.65, P < 0.0001). 
Suppression of NZF-2b/7ZFMyt1 (in animals treated with 
LV-7ZFMyt1-siRNAs) also resulted in 2.2-fold (P < 0.001) decreased 
expression of BDNF compared to LV-GFP group (F
1,12
 = 280.94, 
P < 0.0001). Under these conditions TrkB showed a ∼2-fold inhi-
bition in the LV-7ZFMyt1 group compared to the LV-GFP group 
(P < 0.01) and ∼1.6-fold compared to the LV-7ZFMyt1-siRNA 
group (P < 0.05) (Figure 5B, F
2,12
 = 70.65, P < 0.0001). No signifi -
cant difference was observed between LV-GFP and LV-7ZFMyt1-
siRNA group.
NZF-2b/7ZFMyt1 can also indirectly regulate BDNF expres-
sion through repression of MeCP2 (Liu et al., 2006), which in turn 
regulates REST1 and CoREST expression leading to inhibition of 
BDNF expression (Abuhatzira et al., 2007). qRT-PCR analysis of 
REST1 levels displays signifi cant expression changes that correlate 
with expression changes of NZF-2b/7ZFMyt1 (Figure 5C). The 
different lentivirus-treated animal groups and doxycycline regi-
men that modifi ed NZF-2b/7ZFMyt1 expression also altered REST1 
expression (Figure 5C, F
2,12
 = 33.65, P < 0.0001). In the absence 
of doxycycline a ∼1.8-fold induction of REST1 was observed in 
LV-7ZFMyt1-treated animals (Figure 5C, F
2,12
 = 128.92, P < 0.0001) 
compared to LV-GFP control animals, where it was unaltered by 
doxycycline. Silencing NZF-2b/7ZFMyt1 expression resulted 
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LV-7ZFMyt1 group (∼1.3-fold compared to LV-7ZFMyt1-siRNA 
group, F
1,12
 = 3.00, P = 0.1089). Doxycycline regimen did not alter 
the DAD2R expression profi le of the LV-7ZFMyt1-siRNA or the 
LV-GFP group.
NZF-2b/7ZFMyt1 expression did not cause any signifi cant 
change in the expression of the α-Synuclein and the tetraspanin, 
CD81 (Figure 5E, F
2,12
 = 0.16, P = 0.8550) albeit having putative 
binding sites in their respective promoters. We restricted our gene 
expression analysis with a few genes based on in silico promoter 
analysis data, as analyzing of all the possible genes modulated 
upon NZF-2b/7ZFMyt1 overexpression is beyond the scope of this 
study. Further analysis of genes with putative binding site modules 
for NZF-2b/7ZFMyt1 was nevertheless tested (dopamine trans-
porter, dopamine receptor DAD3R, Sema4C), but interestingly 
FIGURE 5 | NZF-2b/7ZFMyt1 in the NAc specifi cally alters expression of 
several reward-related genes. qRT-PCR quantifi cation of: NAC1 (A); REST1 
(B); the dopamine receptor DAD2R (C); BDNF and its receptor TrkB (D), 
α-Synuclein and the tetraspanin CD81 (E). qRT-PCR was performed from NAc 
tissue of rats (n = 7) bilaterally injected into the NAc with either LV-7ZFMyt1 or the 
LV-7ZFMyt1-siRNAs or LV-GFP (see Materials and Methods). Expression levels 
were calculated relative to cyclophilin. Ectopic expression of NZF-2b/7ZFMyt1 led 
to increased expression of NAC1 (A) REST1 (B), DAD2R (C) and decreased 
expression of BDNF and TrkB (D), whereas it did not signifi cantly modify the 
expression of α-Synuclein and the tetraspanin CD81 (E) and few other genes with 
binding domains for NZF-2b/7ZFMyt1 (data not shown). Doxycycline regimen that 
inhibits ectopic NZF-2b/7ZFMyt1 expression results in a signifi cant decrease in the 
NAC-1 (A) REST1 (B) and DAD2R (C) levels. *P < 0.05; **P < 0.01; ***P < 0.001 
represents values signifi cantly different from lenti-GFP injected rats, and +P < 0.05; 
++P < 0.01; +++P < 0.001 represents values signifi cantly different from LV-7ZFMyt1 
injected rats, by two way ANOVA, Bonferroni post hoc tests.
in ∼1.5-fold decrease in REST1 level compared to LV-GFP-treated 
animals and this level was comparable to saline-treated naive ani-
mals (Chandrasekar and Dreyer, 2010). Under doxycycline regimen 
the levels of REST1 expression in the LV-7ZFMyt1 group dropped 
signifi cantly and was comparable to LV-GFP controls (F
1,12
 = 42.99, 
P < 0.0001).
Expression changes of the dopamine D
2
 receptor (DAD2R) in 
the NAc were analyzed. No signifi cant changes were observed in 
DAD2R levels when LV-7ZFMyt1 or LV-7ZFMyt1-siRNAs groups 
were compared to the control LV-GFP group. In the absence of dox-
ycycline a ∼1.4-fold (P < 0.01) induction of DAD2R was observed 
in LV-7ZFMyt1 treated animals compared to LV-7ZFMyt1-siRNA 
treated animals (Figure 5D, F
2,12
 = 11.02, P = 0.0019), whereas 
under doxycycline the expression levels dropped signifi cantly in the 
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they displayed no signifi cant expression changes in the mRNA 
level, among the different groups and doxycycline treatments (data 
not shown).
DISCUSSION
We have found previously that NZF-2b/7ZFMyt1 is signifi -
cantly induced in the NAc and in the ventral tegmental area after 
chronic cocaine administration and that its expression changes 
in the NAc signifi cantly affects cocaine-mediated  locomotor 
activity (Chandrasekar and Dreyer, 2010). Here we show that 
NZF-2b/7ZFMyt1 overexpression in the NAc signifi cantly inhib-
its self-administration of cocaine, whereas silencing NZF-2b/
7ZFMyt1 increases the motivation to self-administer the drug. 
Both such gain of function and loss of function studies show that 
NZF-2b/7ZFMyt1 alters responsiveness to cocaine and is one of the 
factors mediating behavioral response to cocaine. The behavioral 
effects observed strongly correlate with mRNA and protein expres-
sion of NZF-2b/7ZFMyt1 in the NAc. Immuno- histochemistry 
data show that ectopic NZF-2b/7ZFMyt1 expression in the NAc is 
predominantly localized to the nuclei of neurons, and to a larger 
extent to TH-positive dopaminergic projections areas in the NAc 
and is also observed in a few nuclei of oligodendrocytes. These 
results suggests that the behavioral effects are manifestations 
of the dynamic transcriptional activity of NZF-2b/7ZFMyt1 in 
the NAc.
Ectopic NZF-2b/7ZFMyt1 expression resulted in active 
recruitment and colocalization of HDAC2. NZF-2b/7ZFMyt1 
interacts with Sin3B and with histone deacetylases HDAC1 and 
HDAC2 (Romm et al., 2005) to mediate transcriptional repres-
sion. Our study shows that NZF-2b/7ZFMyt1-induced behavior 
alteration is dependent on its interaction with HDACs, since 
sodium butyrate (NaB) treatment – a potent non-specifi c HDAC 
inhibitor – strongly affected only the LV-Myt1 treated animals, 
but had no effect on LV-GFP and LV-Myt1-siRNAs groups. 
HDAC inhibition increases histone acetylation in the NAc after 
cocaine administration and increases cocaine-mediated locomo-
tor  activity (Kumar et al., 2005) and cocaine conditioned place 
preference (Renthal et al., 2007). Systemic administration of 
low doses (100 mg/kg) of NaB enhances cocaine hyperlocomo-
tor activity (Kumar et al., 2005), whereas cocaine self-adminis-
tration is not affected at such low doses. Only at higher doses 
(400 mg/kg) of NaB augmentation of self-administration was 
observed (Sun et al., 2008). Nevertheless our results show that 
even at 100 mg/kg NaB relieves the suppression of self-admin-
istration caused by ectopic NZF-2b/7ZFMyt1 in LV-7ZFMyt1 
group and brings it back to the control levels. At this dose NaB 
treatment did not affect self- administration in the control LV-
GFP or in the LV-7ZFMyt1-siRNA groups, which clearly suggests 
that NZF-2b/7ZFMyt1 effects are mediated by interaction with 
HDACs and that this interaction is sensitive to very lose doses of 
HDAC inhibitors. Our  double-immunofl ourescence studies sup-
port the view that ectopic NZF-2b/7ZFMyt1 expression resulted 
in HDAC2 recruitment to the neuronal nuclei, possibly leading to 
transcriptional suppression of target genes. Histone hyperacetyla-
tion induced by HDAC inhibition in the presence of cocaine might 
elicits enhanced gene expression specifi c for addiction-like state. 
NaB inhibits most class I and class II histone deacetylases (even 
at the millimolar range) and has been used at much higher doses 
in other studies (1200 mg/kg in Huntington′s model, Ferrante 
et al., 2003; and 630 mg/kg in studying the effects of amphetamine-
induced behavioral effects, Kalda et al., 2007).
We also show evidence supporting our model (Chandrasekar 
and Dreyer, 2010) that ectopic expression of NZF-2b/7ZFMyt1 
might overcome the cytoplasmic recruitment of Lingo1 and its 
transcriptional inhibition, probably by saturating the inhibitor 
complex and thereby causing nuclear localization of NZF-2b/
7ZFMyt1 for transcriptional regulation of its target genes. The 
precise mechanism behind this effect needs further investigation. 
Lingo-1 is an essential component of the Nogo receptor complex 
and is present in neurons and immature oligodendrocytes dur-
ing brain development and in adult brain (Llorens et al., 2008). 
It mediates signaling during critical developmental periods and 
is required for acute growth cone collapse, acting on the neuro-
nal cytoskeleton mainly via Rho kinase (Chivatakarn et al., 2007; 
Llorens et al., 2008). Interaction of NZF-2b/7ZFMyt1 with Lingo1 
is responsible for the intracellular localization and regulation of 
transcriptional activity of NZF-2b/7ZFMyt1, whereby Lingo1 
causes cytoplasmic localization of NZF-2b/7ZFMyt1 and tran-
scriptional inactivation (Llorens et al., 2008). Interestingly BDNF, 
a target of NZF-2b/7ZFMyt1, induces expression of Lingo 1 
(Trifunovski et al., 2004). and a dynamic regulation between 
NZF-2b/7ZFMyt1 and BDNF might determine key events in the 
reward pathway.
From our study, NZF-2b/7ZFMyt1 expression in the NAc 
results in signifi cant expression changes of a number of impor-
tant target genes. Interestingly we found no signifi cant change 
in the mRNA levels of many NZF-2b/7ZFMyt1 putative targets 
like Sema-4C, α-synuclein, the tetraspanin CD81, the dopamine 
transporter and the dopamine receptor DAD3R (that contain 
6, 18, 7, 3 and 12 putative NZF-2b/7ZFMyt1 binding modules, 
respectively; Chandrasekar and Dreyer, 2010), which display no 
signifi cant change after NZF-2b/7ZFMyt1 expression. On the 
other hand, we found signifi cant differential expression of NAC1, 
BDNF, REST1 and DAD2R. This underlies the high specifi city of 
the NZF-2b/7ZFMyt1 action in this cocaine self-administration 
paradigm. NAC1 is a transcriptional repressor whose expression 
is increased in the NAc after prolonged exposure to cocaine; it 
decreases cocaine-induced behavioral sensitization and inter-
acts with HDAC3, HDAC4, along with Co-REST and mSin3a 
(Mackler et al., 2000; Korutla et al., 2002, 2005a,b, 2007; Wang 
et al., 2003). In our study NAC1 was strongly induced by ectopic 
NZF-2b/7ZFMyt1 while doxycycline treatment and silencing 
NZF-2b/7ZFMyt1 brought NAC1 levels down to the LV-GFP 
group, correlating the specifi city of the NAC1 induction with 
NZF-2b/7ZFMyt1 levels. Recent reports have shown that NAC1 
itself lacks DNA binding ability, but acts as a co- repressor (Korutla 
et al., 2009). Elevated levels of NAC1 in the NAc, weeks after 
cocaine administration, may infl uence expression of addicted 
behaviors, such as sensitization, craving and paranoia (Everitt 
and Wolf, 2002). Based on the above fi ndings and our results, 
we propose that induction of NAC1 might be one of the key 
events by which NZF-2b/7ZFMyt1 exerts the observed behavioral 
effects, probably by maintaining a repressed chromatin state for 
certain genes.
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LV-7ZFMyt1 group also showed signifi cant induction of REST1 
in the NAc compared to the LV-GFP control group, whereas the 
LV-7ZFMyt1-siRNA group showed a signifi cant decrease in REST1 
levels. REST1 is a transcriptional repressor required for the acquisition 
of the differentiated functional neuronal phenotype during early devel-
opment (Armisen et al., 2002). REST1 interacts with Co-REST, Sin3A, 
HDAC1 and HDAC2 to maintain a repressive chromatin  environment 
in neural stem cells (Belyaev et al., 2004; Greenway et al., 2006). This 
suggests that induction of REST1 following NZF-2b/7ZFMyt1 expres-
sion after cocaine self-administration probably is important for the 
observed behavioral alterations. Indeed cocaine regulation of chro-
matin-modifying enzymes is currently considered to play a central 
function in shaping the addicted state (Tsankova et al., 2007).
Furthermore we also observed DAD2R induction specifi c to 
NZF-2b/7ZFMyt1 expression. Doxycycline treatment signifi cantly 
reduces DAD2R levels only in the LV-7ZFMyt1 group and silenc-
ing NZF-2b/7ZFMyt1 did not signifi cantly change the DAD2R lev-
els compared to the control group. DAD2R has both presynaptic 
and postsynaptic localization and function; its activation decreases 
PKA-dependent phosphorylation of DARPP-32 at Thr34 (Nishi et al., 
1997; De Mei et al., 2009). Studies have shown that D2-like receptors 
are important in mediating the abuse-related effects of cocaine and 
that DAD2R–/– mice display increased cocaine self-administration 
over wt mice (Caine et al., 2002). Although DAD2R receptor is not 
necessary for cocaine self-administration, it is involved in mecha-
nisms that limit rates of high-dose infusion (Caine et al., 2002). Our 
results suggest that induction of DAD2R by NZF-1b/7ZFMyt1 might 
be a counteractive mechanism to inhibit fi ring and DA discharge 
activity, resulting in the attenuation of cocaine self-administration.
Studies have shown that BDNF mRNA is absent (Castren 
et al., 1995; Altar et al., 1997; Conner et al., 1997) or expressed 
at relatively low levels (Hofer et al., 1990; Graham et al., 2007) in 
dopamine terminal regions such as the NAc under normal con-
ditions, but it is induced markedly following cocaine exposure 
(Filip et al., 2006; Liu et al., 2006) together with its receptor TrkB 
(Bahi et al., 2008). Cocaine self-administration increases BDNF 
protein levels in the VTA, amygdala and accumbens after 30 and 
90 days (but not 1 day) of withdrawal (Grimm et al., 2003). There 
is evidence that BDNF contributes signifi cantly to cocaine behav-
ioural effects (Schoenbaum et al., 2007). This appears essential 
for cocaine-induced behavioral changes (Nestler, 2000; Bahi et al., 
2008; Kalivas and O’Brien, 2008; Thomas et al. 2008). In our study, 
NZF-2b/7ZFMyt1 expression results in downregulation of BDNF. 
This probably occurs via induction of REST1 (Chandrasekar and 
Dreyer, 2010), since BDNF expression is affected by REST1 through 
specifi c interaction with BDNF-RE-1. Decreased levels of REST1 
is needed for activity-dependent gene transcription to occur more 
easily in neuronal cells (Hara et al., 2009). Our present fi nding 
that NZF-2b/7ZFMyt1 expression leads to BDNF suppression 
(probably by induction of REST1) supports the above studies. 
Furthermore NZF-2b/7ZFMyt1 expression also resulted in the 
signifi cant decrease in TrkB, which suggests an inhibition of the 
BDNF-TrkB signaling cascade in the NAc, leading to a decrease in 
cocaine induced activity dependent transcription.
According to current views, compulsive cocaine use and 
cocaine relapse is due to drug-induced neuroadaptations in 
reward-related learning and memory processes, which cause 
hypersensitivity to cocaine-associated cues, impulsive decision 
making and abnormal habit-like learned behaviours that are 
insensitive to adverse conséquences (Thomas and Malenka, 2003; 
Thomas et al., 2008). The transient enhancement in synaptic 
strength after normal reward learning may transform neutral 
stimuli into reward-predictive stimuli, whereas the rescaling of 
synaptic strength after learning would allow for the formation 
of future cue-reward associations (Stuber et al., 2008). Exposure 
to the drug activates selected signalling cascades, growth factors 
and physiological processes implicated in neuroplasticity, that 
include the extracellular signal-regulated kinase (ERK) signalling 
pathway, BDNF, as well as glutamate transmission (Thomas et al., 
2008). These neuro-adaptations have been hypothesized to cause 
hyper-sensitivity to cocaine-associated cues (Di Chiara, 1998; 
Everitt and Wolf, 2002) and impulsive decision making (Volkow 
and Fowler, 2000). As we show, NZF-2b/7ZFMyt1 through its 
action on REST1, DAD2R, BDNF HDAC2 and other downstream 
targets, plays a critical role in these processes. Although analysis 
of all the genes regulated by NZF-2b/7ZFMyt1 and the possi-
ble structural or synaptic strength modifi cations by NZF-2b/
7ZFMyt1 is beyond the scope of the present study, the fewer 
genes analyzed shows the dynamic regulation of target genes by 
NZF-2b/7ZFMyt1 expression, responsible for the attenuation of 
cocaine self-administration observed. Histone modifi cations are 
associated with different transcriptional regulatory mechanisms 
after cocaine administration and specifi c combinations of his-
tone modifi cations correspond to various states of remodeled 
chromatin (activation or repression of distinct sets of genes) 
(Kumar et al., 2005). Our data suggest that NZF-2b/7ZFMyt1 is 
involved in titrating behavioral responses to  psycho-stimulants 
through activating critical upstream events governing multiple 
pathways that differentially contribute to the manifestation of 
the addictive behavior. Such regulation provides a new layer of 
complexity, at the molecular level, through which cocaine pro-
duces neural and behavioral plasticity. Our observation thus 
fi rmly consolidates the current notion that induction of tran-
scriptional events plays a major role in cocaine-induced plasticity 
(Kumar et al., 2005). Clearly NZF-2b/7ZFMyt1 mediates some of 
the local compensatory mechanisms following drug injections. 
In addition NZF2b/7ZFMyt1 so far has been implicated during 
development in the differentiation of myelin cells (mainly oli-
godendrocytes); it controls myelin-expressing genes and matu-
ration of oligodendrocytes which in the nucleus accumbens are 
known to express dopaminergic D3R receptors. Together our data 
may thus also explain many observations describing that altered 
myelin structure and integrity is part of the phenotypic changes 
induced by chronic cocaine abuse in humans and may integrate 
many epigenetic hypotheses in relation to addiction. Therefore 
a better understanding of this transcription factor, also of these 
transcriptional events and the epigenetic mechanisms involved 
in drug administration will facilitate the development of more 
successful drug treatment strategies.
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